
南美洲和中美洲细胞治疗市场预测至 2027 年 - COVID-19 影响和按治疗类型(同种异体、自体)划分的区域分析;产品(消耗品、设备、系统和软件);技术(病毒载体技术、基因组编辑技术、体细胞技术、细胞永生化技术、细胞可塑性技术、三维技术);应用(肿瘤学、心血管、骨科、伤口处理、其他应用);最终用户(研究机构、医院、其他)和国家类别:生物技术
No. of Pages: 123 | Report Code: TIPRE00019135 | Category: Life Sciences
No. of Pages: 123 | Report Code: TIPRE00019135 | Category: Life Sciences
细胞疗法是将活的完整细胞注射、植入或移植到患者体内的过程。这项技术依赖于用健康的功能细胞替代功能失调的细胞。主要用于此类先进疗法的细胞是干细胞,因为它们能够分化成修复受损或有缺陷的组织或细胞所需的特定细胞。此外,细胞疗法在再生医学的开发中也有应用。
南美洲和中美洲细胞治疗市场预计将从 2019 年的 2.719 亿美元增至 2027 年的 4.158 亿美元;预计 2019 年至 2027 年复合年增长率为 5.5%。慢性病患病率不断上升、再生药物的采用不断增加以及细胞疗法的批准数量不断增加等因素预计将在未来几年推动细胞疗法市场的增长。然而,在预测期内,市场可能会受到细胞疗法制造成本高等风险因素的影响。
COVID-19 大流行已成为南美洲和中美洲最重大的挑战地区。巴西和阿根廷等国也登记了大量阳性患者。例如,截至目前,巴西的病例数增至约 882 万例,死亡人数为 21.6 万人。随着第二波COVID-19的爆发,拉丁美洲国家的病例数量不断增加。目前,该国正在迅速增加抗击新型冠状病毒的临床项目。人们越来越关注细胞和基因疗法。例如,巴西血液学、血液治疗和细胞治疗协会成立了一个专家小组,仔细检查和审查细胞疗法在治疗 COVID 19 中的使用。
南美洲和中美洲细胞治疗市场的范围包括治疗类型、产品、技术、应用、最终用户和国家。从治疗类型来看,同种异体细分市场在2019年南美和中美洲细胞治疗市场中占据最大份额。 从产品来看,耗材细分市场在2019年南美和中美洲细胞治疗市场中占据最大份额. 2019年,按技术划分,病毒载体技术领域占据南美洲和中美洲细胞治疗市场的最大份额。就应用而言,肿瘤学领域在2019年占据南美洲和中美洲细胞治疗市场的最大份额。 2019年。就最终用户而言,研究机构细分市场在2019年南美洲和中美洲细胞治疗市场中占据最大份额。
与南美洲和中美洲细胞治疗市场报告相关的几个主要主要和次要来源是世界卫生组织 (WHO)、食品和药物管理局美国药物管理局 (FDA)、美国疾病控制与预防中心 (CDC)、美国癌症协会以及巴西国家卫生监督局或 ANVISA、巴西血液学、血液治疗和细胞治疗协会;以及等等。
Strategic insights for South and Central America Cell Therapy involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2019 | US$ 271.9 Million |
Market Size by 2027 | US$ 415.8 Million |
Global CAGR (2019 - 2027) | 5.5% |
Historical Data | 2017-2018 |
Forecast period | 2020-2027 |
Segments Covered |
By 治疗类型
|
Regions and Countries Covered | 南美洲和中美洲
|
Market leaders and key company profiles |
The regional scope of South and Central America Cell Therapy refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The South and Central America Cell Therapy Market is valued at US$ 271.9 Million in 2019, it is projected to reach US$ 415.8 Million by 2027.
As per our report South and Central America Cell Therapy Market, the market size is valued at US$ 271.9 Million in 2019, projecting it to reach US$ 415.8 Million by 2027. This translates to a CAGR of approximately 5.5% during the forecast period.
The South and Central America Cell Therapy Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South and Central America Cell Therapy Market report:
The South and Central America Cell Therapy Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The South and Central America Cell Therapy Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the South and Central America Cell Therapy Market value chain can benefit from the information contained in a comprehensive market report.